Doximity, Inc. (NASDAQ:DOCS) Shares Bought by Wells Fargo & Company MN

Wells Fargo & Company MN raised its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 368,941 shares of the company's stock after purchasing an additional 11,811 shares during the period. Wells Fargo & Company MN owned about 0.20% of Doximity worth $19,698,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. ExodusPoint Capital Management LP bought a new stake in shares of Doximity in the 4th quarter valued at approximately $2,119,000. Bryce Point Capital LLC bought a new stake in Doximity during the fourth quarter valued at $591,000. Huntington National Bank increased its stake in Doximity by 1,440.8% during the fourth quarter. Huntington National Bank now owns 1,094 shares of the company's stock valued at $58,000 after purchasing an additional 1,023 shares during the last quarter. Trexquant Investment LP acquired a new stake in shares of Doximity during the fourth quarter worth $9,791,000. Finally, Geode Capital Management LLC lifted its position in shares of Doximity by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company's stock worth $157,668,000 after buying an additional 95,458 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on DOCS shares. Needham & Company LLC boosted their price objective on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Truist Financial dropped their price target on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Raymond James restated an "outperform" rating and set a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Finally, Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, Doximity presently has an average rating of "Moderate Buy" and a consensus target price of $65.00.

Doximity Stock Up 0.6 %

NASDAQ DOCS traded up $0.32 on Friday, reaching $53.10. 1,941,624 shares of the stock traded hands, compared to its average volume of 1,983,816. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a market cap of $9.91 billion, a price-to-earnings ratio of 53.10, a P/E/G ratio of 4.10 and a beta of 1.41. The firm's fifty day simple moving average is $62.97 and its 200 day simple moving average is $55.74.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.